90 related articles for article (PubMed ID: 31432577)
1. Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma.
Aotsuka A; Matsumoto Y; Arimoto T; Kawata A; Ogishima J; Taguchi A; Tanikawa M; Sone K; Mori-Uchino M; Tsuruga T; Oda K; Kawana K; Osuga Y; Fujii T
Cancer Sci; 2019 Oct; 110(10):3068-3078. PubMed ID: 31432577
[TBL] [Abstract][Full Text] [Related]
2. Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer.
Maine CJ; Aziz NH; Chatterjee J; Hayford C; Brewig N; Whilding L; George AJ; Ghaem-Maghami S
Cancer Immunol Immunother; 2014 Mar; 63(3):215-24. PubMed ID: 24297569
[TBL] [Abstract][Full Text] [Related]
3. PRDM16 regulates γδT17 cell differentiation via controlling type 17 program and lipid-dependent cell fitness.
Nah J; Lee Y; Seong RH
Front Immunol; 2023; 14():1332386. PubMed ID: 38239368
[TBL] [Abstract][Full Text] [Related]
4. Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1.
Ludwig SD; Meksiriporn B; Tan J; Kureshi R; Mishra A; Kaeo KJ; Zhu A; Stavrakis G; Lee SJ; Schodt DJ; Wester MJ; Kumar D; Lidke KA; Cox AL; Dooley HM; Nimmagadda S; Spangler JB
Cell Chem Biol; 2024 May; 31(5):1023. PubMed ID: 38679021
[No Abstract] [Full Text] [Related]
5. A binary module for microbiota-mediated regulation of γδ17 cells, hallmarked by microbiota-driven expression of programmed cell death protein 1.
Huang HI; Xue Y; Jewell ML; Tan CY; Theriot B; Aggarwal N; Dockterman J; Lin YD; Schroeder EA; Wang D; Xiong N; Coers J; Shinohara ML; Surana NK; Hammer GE
Cell Rep; 2023 Sep; 42(9):113143. PubMed ID: 37682708
[No Abstract] [Full Text] [Related]
6. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
7. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments.
Lopes N; McIntyre C; Martin S; Raverdeau M; Sumaria N; Kohlgruber AC; Fiala GJ; Agudelo LZ; Dyck L; Kane H; Douglas A; Cunningham S; Prendeville H; Loftus R; Carmody C; Pierre P; Kellis M; Brenner M; Argüello RJ; Silva-Santos B; Pennington DJ; Lynch L
Nat Immunol; 2021 Feb; 22(2):179-192. PubMed ID: 33462452
[TBL] [Abstract][Full Text] [Related]
8. Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).
Fukuoka S; Hara H; Takahashi N; Kojima T; Kawazoe A; Asayama M; Yoshii T; Kotani D; Tamura H; Mikamoto Y; Hirano N; Wakabayashi M; Nomura S; Sato A; Kuwata T; Togashi Y; Nishikawa H; Shitara K
J Clin Oncol; 2020 Jun; 38(18):2053-2061. PubMed ID: 32343640
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
Liu C; Yao Z; Wang J; Zhang W; Yang Y; Zhang Y; Qu X; Zhu Y; Zou J; Peng S; Zhao Y; Zhao S; He B; Mi Q; Liu X; Zhang X; Du Q
Cell Death Differ; 2020 Jun; 27(6):1765-1781. PubMed ID: 31802034
[TBL] [Abstract][Full Text] [Related]
10. IL-17 inhibits CXCL9/10-mediated recruitment of CD8
Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K
J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909
[TBL] [Abstract][Full Text] [Related]
11. VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers.
Kim CG; Jang M; Kim Y; Leem G; Kim KH; Lee H; Kim TS; Choi SJ; Kim HD; Han JW; Kwon M; Kim JH; Lee AJ; Nam SK; Bae SJ; Lee SB; Shin SJ; Park SH; Ahn JB; Jung I; Lee KY; Park SH; Kim H; Min BS; Shin EC
Sci Immunol; 2019 Nov; 4(41):. PubMed ID: 31704735
[TBL] [Abstract][Full Text] [Related]
12. IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells.
Wei Y; Shi D; Liang Z; Liu Y; Li Y; Xing Y; Liu W; Ai Z; Zhuang J; Chen X; Gao Q; Jiang J
J Hepatol; 2019 Dec; 71(6):1206-1215. PubMed ID: 31499129
[TBL] [Abstract][Full Text] [Related]
13. A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites.
Chen W; Liu H; Huang X; Qian L; Chen L; Zhou Y; Liu Y; Liu Y; Wang Y; Zhang T; Zhou Y; Fang J; Yang J; Ni F; Guo C; Zhou Y
iScience; 2023 Oct; 26(10):107712. PubMed ID: 37701567
[TBL] [Abstract][Full Text] [Related]
14. Tumor Immune Microenvironment in Gynecologic Cancers.
Margul D; Yu C; AlHilli MM
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568665
[TBL] [Abstract][Full Text] [Related]
15. PD-L1: expression regulation.
Zhou YJ; Li G; Wang J; Liu M; Wang Z; Song Y; Zhang X; Wang X
Blood Sci; 2023 Apr; 5(2):77-91. PubMed ID: 37228770
[TBL] [Abstract][Full Text] [Related]
16. Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment.
Gao Z; Bai Y; Lin A; Jiang A; Zhou C; Cheng Q; Liu Z; Chen X; Zhang J; Luo P
Mol Cancer; 2023 Feb; 22(1):31. PubMed ID: 36793048
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy.
Shi L; Lu J; Zhong D; Song M; Liu J; You W; Li WH; Lin L; Shi D; Chen Y
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657812
[TBL] [Abstract][Full Text] [Related]
18. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment.
Lian J; Liang Y; Zhang H; Lan M; Ye Z; Lin B; Qiu X; Zeng J
Front Immunol; 2022; 13():912279. PubMed ID: 36119047
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy.
Liontos M; Andrikopoulou A; Koutsoukos K; Markellos C; Skafida E; Fiste O; Kaparelou M; Thomakos N; Haidopoulos D; Rodolakis A; Dimopoulos MA; Zagouri F
J Ovarian Res; 2021 Nov; 14(1):148. PubMed ID: 34724958
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.
Zhang D; Zou D; Deng Y; Yang L
J Ovarian Res; 2021 Sep; 14(1):120. PubMed ID: 34526089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
